Bethesda. Manual de hematología clínica

C O L A B O R A D O R E S

Inhy e E. A hn, MD  Sta ff C linician, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland Daisuke Araki, MD  Hematology Fellow, Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland A. John Barrett, MD  Section Chief, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland Minoo Battiwalla, MD, MS  Sta ff C linician, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland Deepa Bhojwani, MD  Associate Professor, Clinical Pediatrics, Pediatrics, Keck School of Medicine, University of Southern California; Director, Leukemia/​Lymphoma Program, Pediatrics, Children’s Hospital Los Angeles, Los Angeles, California Charles D . B olan, MD  Sta ff C linician, Hematology Branch, National Heart, Lung, and Blood Institute, Clinical Center, National Institutes of Health, Bethesda, Maryland Rau l C. B raylan, MD  Chief, Hematology Laboratory, Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland Katherine R . C alvo, MD, PhD  Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland Richard W . C hilds, MD  Chief, Transplantation Immunotherapy Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland Bogdan Dumitriu, MD  Sta ff C linician, Hematology Oncology Department, Mid Atlantic Permanente Medical Group, Rockville, Maryland Cynthi a E. D unbar, MD  Senior Investigator and Section Head, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland Th oma s A. F leisher, MD  Scientist Emeritus, Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland Patrick F . F ogarty, MD  Medical A ff airs, Hemophilia, Rare Disease , Pfiz er, Collegeville, Pennsylvania

Peiman Hematti , MD  Professor, Department of Medicine, University of Wisconsin-​Madison, School of Medicine and Public Health, Madison, Wisconsin Christophe r S. H ourigan, BM BCh, DPhil  Chief, Myeloid Malignancies Section, Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland Matthe w M. H sieh, MD  Sta ff C linician, Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland Julie Ja ff ray, MD  Assistant Professor, Department of Pediatrics, University of Southern California; Hematologist, Division of Hematology, Children’s Hospital Los Angeles, Los Angeles, California Dickran Kazandjian, MD  Principal Investigator, Myeloma Program, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Attending Physician, O ffic e of Hematology and Oncology Products, Food and Drug Administration, Silver Spring, Maryland Harve y G. K lein, MD  Adjunct Professor, Medicine and Pathology , Th e Johns Hopkins School of Medicine; Chief, Department of Transfusion Medicine, Warre n G. M agnuson Clinical Center, Bethesda, Maryland Neha Korde, MD  Assistant Professor, Department of Medicine, Weill Cornell Medical College; Assistant Attending, Department of Medicine, Memorial Sloan Kettering Cancer Center, Ne w Y ork, Ne w Y ork Ola Landgren, MD, PhD  Professor, Department of Medicine, Weill Cornell Medical College; Chief of Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Ne w Y ork, Ne w Y ork Susan F . L eitman, MD  Director, O ffic e of Clinical Research, Training and Medical Education, National Institutes of Health; Special Volunteer, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland Vid Leko, MD  Clinical Fellow, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland

AMPLE

vii